
Ocugen, Inc.: updates and filings
Price
$0.77
November 20, 2026Market cap $252M
What Ploutos Investor adds for Ocugen
Part of Ploutos Investor, €9.99 a month
- The full history: 12 fiscal years, from 2014
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 4, 2026next Feb 5, 2027
A rough estimate from when it has reported before, which has varied. The company announces the date itself.
November 2026
October 2026
September 2026
August 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 10, 2026Material agreement entered, Regulation FD disclosureForm8-K
- Nov 6, 2026Additional annual meeting materialFormDEFA14A
- Nov 6, 2026Additional annual meeting materialFormDEFA14A
- Nov 4, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 4, 2026Results of operationsForm8-K
- Oct 15, 2026Regulation FD disclosureForm8-K
- Oct 15, 2026Material agreement entered, Regulation FD disclosure, other material eventsForm8-K
- Oct 6, 2026Shareholder voteForm8-K
- Sep 23, 2026Shareholder voteForm8-K
- Sep 8, 2026Regulation FD disclosure, other material eventsForm8-K
- Aug 14, 2026Additional annual meeting materialFormDEFA14A
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 7, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 6, 2026Results of operationsForm8-K
- Jul 30, 2026Additional annual meeting materialFormDEFA14A
- Jul 30, 2026Annual meeting proxy statementFormDEF 14A
- Jul 29, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 20, 2026Preliminary proxy statementFormPRE 14A
- Jul 13, 2026Other material eventsForm8-K
- Jun 11, 2026Shareholder vote, other material eventsForm8-K
- Jun 3, 2026Officer or director changeForm8-K
- May 14, 2026Officer or director change, other material eventsForm8-K
- May 14, 2026New material financial obligation, unregistered sale of shares, Regulation FD disclosureForm8-K
- May 8, 2026Quarterly reportfor the period to Mar 31, 2026Form10-Q
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 10, 2026 | 8-K | Material agreement entered, Regulation FD disclosure | Document |
| Nov 6, 2026 | DEFA14A | Additional annual meeting material | Document |
| Nov 6, 2026 | DEFA14A | Additional annual meeting material | Document |
| Nov 4, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 4, 2026 | 8-K | Results of operations | Document |
| Oct 15, 2026 | 8-K | Regulation FD disclosure | Document |
| Oct 15, 2026 | 8-K | Material agreement entered, Regulation FD disclosure, other material events | Document |
| Oct 6, 2026 | 8-K | Shareholder vote | Document |
| Sep 23, 2026 | 8-K | Shareholder vote | Document |
| Sep 8, 2026 | 8-K | Regulation FD disclosure, other material events | Document |
| Aug 14, 2026 | DEFA14A | Additional annual meeting material | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 7, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 6, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 6, 2026 | 8-K | Results of operations | Document |
| Jul 30, 2026 | DEFA14A | Additional annual meeting material | Document |
| Jul 30, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jul 29, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 20, 2026 | PRE 14A | Preliminary proxy statement | Document |
| Jul 13, 2026 | 8-K | Other material events | Document |
| Jun 11, 2026 | 8-K | Shareholder vote, other material events | Document |
| Jun 3, 2026 | 8-K | Officer or director change | Document |
| May 14, 2026 | 8-K | Officer or director change, other material events | Document |
| May 14, 2026 | 8-K | New material financial obligation, unregistered sale of shares, Regulation FD disclosure | Document |
| May 8, 2026 | 10-Q | Quarterly reportfor the period to Mar 31, 2026 | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Aug 7, 2006.
The full analysis
What do Ocugen's filings show?
The filings are where every one of Ocugen's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.